Urinary EGF and MCP1 levels have already been individually associated with increased risk of CKD progression in ADPKD patients [12–14], while the ratio of these two cytokines (uEGF/MCP1) has proven to be a useful prognostic biomarker in IgA nephropathy [15]. Here, CCL2 is linked to chronic kidney disease.